J Reconstr Microsurg 2004; 20(3): 261-266
DOI: 10.1055/s-2004-823114
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Effect of Topical Nitroglycerine on the Survival of Ischemic Flow-Through Venous Flaps in Rabbits

Atilla Coruh1 , Kamil Abaci2 , Galip Kemali Gunay1
  • 1Department of Plastic and Reconstructive Surgery, Erciyes University Medical Faculty, Kayseri, Turkey
  • 2Afyon State Hospital, Afyon, Turkey
Weitere Informationen

Publikationsverlauf

Accepted: 2 December 2003

Publikationsdatum:
16. April 2004 (online)

Preview

The purpose of this study was to investigate the effect of transdermal nitroglycerin on the survival of an ischemic one-vein flow-through venous flap (FTVF) model in the rabbit ear. Fifteen New Zealand white male rabbits were randomly divided into three groups: Group 1 (n = 5, 10 flaps)- no dressing on the operative wound; Group 2 (n = 5, 10 flaps)-occlusive film dressing group [polyurethane semipermeable membrane (Op-Site®)]; and Group 3 (n = 5, 10 flaps)- transdermal nitroglycerine pad (Novartis-Nitroderm TTS 5 mg) on the wound. Nitroderm TTS and the occlusive film dressing were changed daily postoperatively for 3 days. The percentage of the surviving area and the mean extent of the surviving area to the axial vein were calculated on the postoperative 14th day. Necrotic and surviving areas of flaps were consistent with histopathologic findings. Group 3 (83 percent ±10.46, 17.4 ± 3.0 mm) had larger flap surviving areas and longer distances to the axial vein than Group 1 (60 percent ±15.29, 11.8 ± 4.3 mm) and Group 2 (58 percent ±10.25, 12.8 ± 2.8 mm). The difference was statistically significant (p < 0.05). This study demonstrated that postoperatively applied transdermal nitroglycerine significantly increased the ischemic FTVF survival area and the survival width to the axial vein.

REFERENCES

Atilla CoruhM.D. 

Alpaslan Mahallesi, Esref Bitlis Bulvari, Imag Sitesi

12/A, Kat: 13, Daire: 26

Kayseri, Turkey